Enopia, Enelyn O.
HRN: 24-48-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/04/2024
CEFTRIAXONE 1G (VIAL)
02/04/2024
02/11/2024
IV
2g
OD
Multiple Lacerated Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes